Dossenheim, Germany

Bernd Simon

This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernd Simon. Retrieved from https://idiyas.com/inventor/bernd-simon-cyaqeavu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bernd Simon: Innovator in Cytoprotective Compounds

Introduction

Bernd Simon is a notable inventor based in Dossenheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with cytoprotective activity.

Latest Patents

Simon holds a patent for 13-thiaprostaglandins, which are compounds that exhibit cytoprotective properties. The patent details the specific formula of these compounds, which is represented as 13-thiaprostaglandins of Formula I, wherein B is either --CH.sub.2 --CH.sub.2 -- or --CH.dbd.CH--. This innovation has potential applications in various therapeutic areas.

Career Highlights

Bernd Simon is associated with Merck Patent Gesellschaft mit beschränkter Haftung, a prominent company in the pharmaceutical industry. His work at Merck has allowed him to focus on innovative research and development in drug formulation and delivery.

Collaborations

Throughout his career, Simon has collaborated with esteemed colleagues, including Hanns-Gerd Dammann and Peter Muller. These partnerships have contributed to the advancement of research in the field of cytoprotective agents.

Conclusion

Bernd Simon's contributions to the field of pharmaceuticals, particularly through his patent on 13-thiaprostaglandins, highlight his role as an innovator. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…